Lv1
8 积分 2023-11-30 加入
Navigating the landscape of EGFR TKI resistance in EGFR-mutant NSCLC — mechanisms and evolving treatment approaches
1个月前
已完结
NNMT inhibition in cancer-associated fibroblasts restores antitumour immunity
1个月前
已完结
Targeting TFAP2β condensation suppresses the development of esophageal squamous cell carcinoma
3个月前
已完结
Bispecific T-cell Engager (CD3 × EGFR)-Based Triplet Therapy Unlocks CD40/CD40L Crosstalk to Revert Immunosuppression in Third-Generation EGFR-Tyrosine Kinase Inhibitor–Refractory NSCLC
3个月前
已完结
Targeting RNA adenosine editing and modification enzymes for RNA therapeutics
5个月前
已完结
TWF2 Drives Tumor Progression and Sunitinib Resistance in Renal Cell Carcinoma through Hippo Signaling Suppression
5个月前
已完结
METTL3-m6A-EGFR-axis drives lenvatinib resistance in hepatocellular carcinoma
5个月前
已完结
Automated daily report generation from construction videos using ChatGPT and computer vision
6个月前
已完结
Targeted Therapies for Lung Cancer Patients With Oncogenic Driver Molecular Alterations
6个月前
已完结
Dual targeting of PI3K and mTOR induce necroptosis to enhance therapeutic efficacy in pancreatic neuroendocrine tumors
8个月前
已完结
皖公网安备34019202002308
